DGX logo

DGX

Profile

Full Name

Quest Diagnostics Incorporated

Ticker Symbol

DGX

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

December 17, 1996

Indexes

S&P 500

Website

http://www.questdiagnostics.com

Employees

45000

Key Details

Price

$167.23(-0.46%)

Market cap

Last Dividend

$0.80

TTM Dividend yield

1.82%

Annual revenue

$9.87B(+6.70% YoY)

Annual EPS

$7.69(+2.67% YoY)

PE ratio

21.75

Next earnings date

Apr 22, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$167.23
DGX price is $167.23

30-Day Relative Volume

0.80
DGX 30-day relative volume is 0.80

Price Performance

Price Today change

-0.46%
DGX price is down -0.46% today

Price YTD change

+10.85%
DGX price is up +10.85% since January 1st

Price 1-year change

+30%
DGX price is up +30% year-on-year

Price 3-year change

+23.04%
DGX price is up +23.04% over the past 3 years

Price Range

Price All-time high

$178.87
DGX price is currently -6.51% below its historical high of $178.87

Price 3-year low

$119.59
DGX price is currently +39.84% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$18.56B
DGX market capitalization is $18.56 billion

Market cap 3-year change

+16.34%
DGX market capitalization is up +16.34% over the past 3 years

Market cap All-time high

$21.09B
DGX market capitalization is currently -11.99% below its historical high of $21.09 billion

Market cap sector rank

95.39%
DGX market capitalization is higher than 95.39% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.02%
DGX shares outstanding is down -0.02% year-on-year

Shares Outstanding 3-Year Change

-5.44%
DGX shares outstanding is down -5.44% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.24
DGX beta is 0.24

200-day SMA

$156.64
DGX price is currently +6.76% above its 200-day simple moving average

50-day SMA

$168.63
DGX price is currently -0.83% below its 50-day simple moving average

RSI

50.83
DGX 14-day relative strength index is 50.83

Volume

0.80
DGX 30-day relative volume is 0.80

ATR

$5.10
DGX average true range is $5.10

10-day Historical Volatility

32.70%
DGX 10-day historical volatility is 32.70%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.80
DGX last dividend was $0.80 per share, with an ex-dividend date of April 7, 2025

Next Dividend

-
DGX next dividend has not yet been announced

Dividend per share

Dividend per share

$2.96
DGX annual dividend per share is $2.96

Dividend per share Sector Rank

82.56%
DGX annual dividend per share is higher than 82.56% of companies in Healthcare sector

Dividend per share 1-Year Change

+6.09%
DGX annual dividend per share is up +6.09% year-on-year

Dividend per share 3-Year Change

+22.31%
DGX annual dividend per share is up +22.31% over the past 3 years

Dividend yield

Dividend yield

1.77%
DGX annual dividend yield is 1.77%

Dividend yield Sector Rank

45.88%
DGX annual dividend yield is higher than 45.88% of companies in Healthcare sector

Other

Payout ratio

38.00%
DGX annual payout ratio is 38.00%

Dividends paid

$331.00M
DGX annual dividends paid is $331.00 million

Free cash flow

$909.00M
DGX annual free cash flow is $909.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$9.87B
DGX annual revenue is $9.87 billion

Revenue Analysts estimate

$10.78B
DGX annual revenue is currently -8.44% lower than the consensus analysts' forecast

Revenue 1-year change

+6.7%
DGX annual revenue is up +6.7% year-on-year

Revenue Sector rank

94.18%
DGX annual revenue is higher than 94.18% of companies in Healthcare sector

EPS

EPS

$7.69
DGX annual earnings per share is $7.69

EPS Analysts estimate

$9.69
DGX annual earnings per share is currently -20.62% lower than the consensus analysts' forecast

EPS 1-year change

+2.67%
DGX annual earnings per share is up +2.67% year-on-year

EPS Sector rank

97.6%
DGX annual earnings per share is higher than 97.6% of companies in Healthcare sector

Profit

Gross profit

$3.24B
DGX annual gross profit is $3.24 billion

Gross margin

32.86%
DGX annual gross profit margin is 32.86%

Operating profit

$1.35B
DGX annual operating income is $1.35 billion

Operating margin

13.63%
DGX annual operating profit margin is 13.63%

Net income

$871.00M
DGX annual net profit is $871.00 million

Net margin

8.82%
DGX annual net profit margin is 8.82%

Expenses

Total expenses

$8.53B
DGX annual total expenses is $8.53 billion

Operating expenses

$1.90B
DGX annual total operating expenses is $1.90 billion

Cost of goods sold

$6.63B
DGX annual cost of goods sold is $6.63 billion

Selling, general & administrative expenses

$1.77B
DGX annual SGA is $1.77 billion

Depreciation and amortization

$493.00M
DGX annual depreciation & amortization is $493.00 million

Interest expense

$226.00M
DGX annual interest expense is $226.00 million

Income tax

$273.00M
DGX annual income tax is $273.00 million

EBIT & EBITDA

EBIT

$1.38B
DGX annual earnings before interest & taxes is $1.38 billion

EBITDA

$1.87B
DGX annual EBITDA is $1.87 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$16.15B
DGX annual total assets is $16.15 billion

Non current assets

$13.76B
DGX annual long term assets is $13.76 billion

Current assets

$2.39B
DGX annual total current assets is $2.39 billion

Cash and cash equivalents

$549.00M
DGX annual cash & cash equivalents is $549.00 million

Accounts receivable

$1.30B
DGX annual accounts receivable is $1.30 billion

Inventory

$188.00M
DGX annual inventory is $188.00 million

Liabilities

Total liabilities

$9.26B
DGX annual total liabilities is $9.26 billion

Long term liabilities

$7.09B
DGX annual total long term liabilities is $7.09 billion

Current liabilities

$2.17B
DGX annual total current liabilities is $2.17 billion

Accounts payable

$287.00M
DGX annual accounts payable is $287.00 million

Debt

Total debt

$6.92B
DGX annual total debt is $6.92 billion

Total debt 1-year change

+25.95%
DGX annual total debt is up +25.95% year-on-year

Long term debt

$6.15B
DGX annual long term debt is $6.15 billion

Short term debt

$775.00M
DGX annual short term debt is $775.00 million

Equity & Capital

Shareholders equity

$6.78B
DGX annual stockholders equity is $6.78 billion

Book value

$6.78B
DGX annual book value is $6.78 billion

Retained earnings

$9.36B
DGX annual retained earnings is $9.36 billion

Working capital

$223.00M
DGX annual working capital is $223.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.33B
DGX annual cash flow from operations is $1.33 billion

Cash from operations 1-year change

+4.87%
DGX annual cash flow from operations is up +4.87% year-on-year

Cash from investing

-$2.55B
DGX annual cash flow from investing activities is -$2.55 billion

Cash from investing 1-year change

-140.15%
DGX annual cash flow from investing activities is down -140.15% year-on-year

Cash from financing

$1.08B
DGX annual cash flow from financing activities is $1.08 billion

Cash from financing 1-year change

+577.5%
DGX annual cash flow from financing activities is up +577.5% year-on-year

CAPEX

CAPEX

$425.00M
DGX annual capital expenditures is $425.00 million

CAPEX 1-year change

+4.17%
DGX annual capital expenditures is up +4.17% year-on-year

Free Cash Flow

Free cash flow

$909.00M
DGX annual free cash flow is $909.00 million

Free cash flow 1-year change

+5.21%
DGX annual free cash flow is up +5.21% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

32.86%
DGX annual gross profit margin is 32.86%

Operating margin

13.63%
DGX annual operating profit margin is 13.63%

Net margin

8.82%
DGX annual net profit margin is 8.82%

ROA & ROE

ROA

5.77%
DGX annual return on assets is 5.77%

ROE

13.08%
DGX annual return on equity is 13.08%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

21.75
DGX price to earnings ratio is 21.75

PE ratio Sector rank

42.16%
DGX price to earnings ratio is higher than 42.16% of companies in Healthcare sector

PB Ratio

PB ratio

2.74
DGX price to book ratio is 2.74

PB ratio Sector rank

70.78%
DGX price to book ratio is higher than 70.78% of companies in Healthcare sector

PS Ratio

PS ratio

1.88
DGX price to sales ratio is 1.88

PS ratio Sector rank

42.31%
DGX price to sales ratio is higher than 42.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$25.10B
DGX enterprise value is $25.10 billion

Enterprise value Sector rank

95.95%
DGX enterprise value is higher than 95.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.30
DGX EV/EBITDA is 13.30

EV/EBITDA Sector rank

86%
DGX EV/EBITDA is higher than 86% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.10
DGX annual current ratio is 1.10

Quick ratio

1.02
DGX annual quick ratio is 1.02

Leverage

Debt to equity

0.92
DGX annual debt to equity ratio is 0.92

Interest coverage ratio

6.09
DGX annual interest coverage ratio is 6.09

Risk & Stability

Piotroski F-Score

6
DGX piotroski f-score is 6

Altman Z-Score

2.92
DGX altman z-score is 2.92

Analyst ratings

Recent major analysts updates

Apr 9, 25 Mizuho
Outperform
Apr 2, 25 Redburn Atlantic
Buy
Mar 20, 25 Baird
Outperform
Mar 4, 25 Citigroup
Neutral
Feb 4, 25 JP Morgan
Neutral
Feb 3, 25 UBS
Neutral
Feb 3, 25 Piper Sandler
Neutral
Feb 3, 25 Mizuho
Outperform
Jan 31, 25 Truist Securities
Hold
Jan 31, 25 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

MOH logo
Molina Healthcare (MOH)
LH logo
Laboratory Corporation of America Holdings (LH)
SMMT logo
Summit Therapeutics (SMMT)
PODD logo
Insulet (PODD)
WAT logo
Waters (WAT)
ZBH logo
Zimmer Biomet Holdings (ZBH)
BIIB logo
Biogen (BIIB)
NTRA logo
Natera (NTRA)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
  • What is the ticker symbol for Quest Diagnostics Incorporated?
  • Does Quest Diagnostics Incorporated pay dividends?
  • What sector is Quest Diagnostics Incorporated in?
  • What industry is Quest Diagnostics Incorporated in?
  • What country is Quest Diagnostics Incorporated based in?
  • When did Quest Diagnostics Incorporated go public?
  • Is Quest Diagnostics Incorporated in the S&P 500?
  • Is Quest Diagnostics Incorporated in the NASDAQ 100?
  • Is Quest Diagnostics Incorporated in the Dow Jones?
  • When was Quest Diagnostics Incorporated's last earnings report?
  • When does Quest Diagnostics Incorporated report earnings?
  • Should I buy Quest Diagnostics Incorporated stock now?

What is the ticker symbol for Quest Diagnostics Incorporated?

The ticker symbol for Quest Diagnostics Incorporated is NYSE:DGX

Does Quest Diagnostics Incorporated pay dividends?

Yes, Quest Diagnostics Incorporated pays dividends. The last payment was $0.80, with an ex-dividend date on April 7, 2025

What sector is Quest Diagnostics Incorporated in?

Quest Diagnostics Incorporated is in the Healthcare sector

What industry is Quest Diagnostics Incorporated in?

Quest Diagnostics Incorporated is in the Diagnostics & Research industry

What country is Quest Diagnostics Incorporated based in?

Quest Diagnostics Incorporated is headquartered in United States

When did Quest Diagnostics Incorporated go public?

Quest Diagnostics Incorporated's initial public offering (IPO) was on December 17, 1996

Is Quest Diagnostics Incorporated in the S&P 500?

Yes, Quest Diagnostics Incorporated is included in the S&P 500 index

Is Quest Diagnostics Incorporated in the NASDAQ 100?

No, Quest Diagnostics Incorporated is not included in the NASDAQ 100 index

Is Quest Diagnostics Incorporated in the Dow Jones?

No, Quest Diagnostics Incorporated is not included in the Dow Jones index

When was Quest Diagnostics Incorporated's last earnings report?

Quest Diagnostics Incorporated's most recent earnings report was on Jan 30, 2025

When does Quest Diagnostics Incorporated report earnings?

The next expected earnings date for Quest Diagnostics Incorporated is Apr 22, 2025

Should I buy Quest Diagnostics Incorporated stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page